Synlogic, Inc. (SYBX)
1.05
+0.05
(+5.00%)
USD |
OTCM |
Oct 23, 16:00
Synlogic EPS Diluted (Quarterly) : -0.0437 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0437 |
| March 31, 2026 | 0.0549 |
| December 31, 2025 | 0.1289 |
| September 30, 2025 | -0.1868 |
| June 30, 2025 | -0.0429 |
| March 31, 2025 | 0.0256 |
| December 31, 2024 | -0.061 |
| September 30, 2024 | -0.0096 |
| June 30, 2024 | 0.2482 |
| March 31, 2024 | -2.111 |
| December 31, 2023 | -1.705 |
| September 30, 2023 | -2.570 |
| June 30, 2023 | -3.214 |
| March 31, 2023 | -3.393 |
| December 31, 2022 | -3.540 |
| September 30, 2022 | -3.726 |
| June 30, 2022 | -3.296 |
| March 31, 2022 | -3.272 |
| December 31, 2021 | -3.247 |
| September 30, 2021 | -4.342 |
| June 30, 2021 | -4.174 |
| March 31, 2021 | -5.405 |
| December 31, 2020 | -5.755 |
| September 30, 2020 | -5.464 |
| June 30, 2020 | -6.664 |
| Date | Value |
|---|---|
| March 31, 2020 | -6.935 |
| December 31, 2019 | -5.950 |
| September 30, 2019 | -5.824 |
| June 30, 2019 | -6.797 |
| March 31, 2019 | -7.677 |
| December 31, 2018 | -7.082 |
| September 30, 2018 | -6.396 |
| June 30, 2018 | -8.824 |
| March 31, 2018 | -8.313 |
| December 31, 2017 | -11.10 |
| September 30, 2017 | -24.90 |
| June 30, 2017 | -493.55 |
| March 31, 2017 | -471.63 |
| December 31, 2016 | -389.17 |
| September 30, 2016 | -349.65 |
| June 30, 2016 | -28.35 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | -39.24 |
| June 30, 2015 | -36.43 |
| March 31, 2015 | -27.20 |
| December 31, 2014 | -25.66 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | -18.66 |
| March 31, 2014 | -18.81 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | -0.0146 |
| Amgen, Inc. | 4.366 |
| Anika Therapeutics, Inc. | 0.2412 |
| BioCryst Pharmaceuticals, Inc. | 0.2957 |
| Imunon, Inc. | -0.5412 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.543M |
| Total Expenses (Quarterly) | 0.543M |
| Enterprise Value | -0.9016M |
| Earnings Yield | -4.45% |
| Normalized Earnings Yield | -19.20 |